首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1491589

全球自動注射器市場 2024-2028

Global autoinjectors market 2024-2028

出版日期: 2024年05月21日 | 出版商:

TechNavio | 英文 176 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計2023-2028年自動注射器市場將成長3,036.554億美元，預測期內複合年成長率為36.72%。

該報告包括對自動注射器市場的總體分析、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括過敏症的日益流行和即時治療的需求、注射療法的日益普及以及新產品的商業批准不斷增加。

市場範圍
基準年	2024年
結束年份	2028年
預測期	2024-2028
成長動力	加速度
2024年與前一年同期比較	27%
複合年成長率	36.72%
增量	303,655.4 百萬美元

研究指出，公司之間的策略聯盟將成為未來幾年推動自動注射器市場成長的關鍵因素之一。此外，越來越多的新產品推出以及對創新過敏自動注射器的認知不斷提高也將帶來強勁的市場需求。

區域細分
區域比較
北美：2023-2028 年市場規模與預測
歐洲：2023-2028 年市場規模與預測
亞洲：2023-2028年市場規模與預測
世界其他地區：2023-2028 年市場規模與預測
美國：2023-2028 年市場規模與預測
英國：2023-2028 年市場規模與預測
德國：2023-2028年市場規模與預測
加拿大：2023-2028 年市場規模與預測
中國：2023-2028年市場規模及預測
市場機會：依地區狀況

第10章促進因素、挑戰、機會、限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第11章競爭格局

概述
競爭格局
混亂的情況
產業風險

第12章競爭分析

公司簡介
公司市場定位
AbbVie Inc.
Amgen Inc.
Bayer AG
Becton Dickinson and Co.
Eli Lilly and Co.
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Halozyme Therapeutics Inc.
Merck KGaA
Owen Mumford Ltd.
Pfizer Inc.
Recipharm AB
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Ypsomed Holding AG

第13章附錄

簡介目錄圖表

Product Code: IRTNTR70391

The autoinjectors market is forecasted to grow by USD 303655.4 mn during 2023-2028, accelerating at a CAGR of 36.72% during the forecast period. The report on the autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies and need for immediate care, growing popularity of injectable therapies, and rise in commercial approvals of new products.

Technavio's autoinjectors market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	27%
CAGR	36.72%
Incremental Value	$303655.4mn

ByApplication

Anaphylaxis
Multiple sclerosis
Rheumatoid arthritis
Diabetes

ByEnd-user

Hospitals and clinics
Self-administration

ByGeography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strategic alliances between companies as one of the prime reasons driving the autoinjectors market growth during the next few years. Also, increase in new product launches and rise in awareness of innovative anaphylaxis autoinjectors will lead to sizable demand in the market.

The report on the autoinjectors market covers the following areas:

Autoinjectors market sizing
Autoinjectors market forecast
Autoinjectors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoinjectors market vendors that include AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Halozyme Therapeutics Inc., Johnson and Johnson Services Inc., Johnson Medtech LLC, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., RAVIMED Sp. zoo, Recipharm AB, SHL Medical AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG. Also, the autoinjectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Autoinjectors Market 2018 - 2022
- Historic Market Size - Data Table on Global Autoinjectors Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
6.3 Anaphylaxis - Market size and forecast 2023-2028
- Chart on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
- Data Table on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
- Chart on Anaphylaxis - Year-over-year growth 2023-2028 (%)
- Data Table on Anaphylaxis - Year-over-year growth 2023-2028 (%)
6.4 Multiple sclerosis - Market size and forecast 2023-2028
- Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
- Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
- Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
- Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
6.5 Rheumatoid arthritis - Market size and forecast 2023-2028
- Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
- Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
- Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
- Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
6.6 Diabetes - Market size and forecast 2023-2028
- Chart on Diabetes - Market size and forecast 2023-2028 ($ million)
- Data Table on Diabetes - Market size and forecast 2023-2028 ($ million)
- Chart on Diabetes - Year-over-year growth 2023-2028 (%)
- Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2023-2028
- Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
7.4 Self-administration - Market size and forecast 2023-2028
- Chart on Self-administration - Market size and forecast 2023-2028 ($ million)
- Data Table on Self-administration - Market size and forecast 2023-2028 ($ million)
- Chart on Self-administration - Year-over-year growth 2023-2028 (%)
- Data Table on Self-administration - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
12.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
12.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
12.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
12.7 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.10 Halozyme Therapeutics Inc.
- Halozyme Therapeutics Inc. - Overview
- Halozyme Therapeutics Inc. - Product / Service
- Halozyme Therapeutics Inc. - Key offerings
12.11 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
12.12 Owen Mumford Ltd.
- Owen Mumford Ltd. - Overview
- Owen Mumford Ltd. - Product / Service
- Owen Mumford Ltd. - Key offerings
12.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
12.14 Recipharm AB
- Recipharm AB - Overview
- Recipharm AB - Business segments
- Recipharm AB - Key offerings
- Recipharm AB - Segment focus
12.15 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
12.17 Ypsomed Holding AG
- Ypsomed Holding AG - Overview
- Ypsomed Holding AG - Business segments
- Ypsomed Holding AG - Key offerings
- Ypsomed Holding AG - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Autoinjectors Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Application - Market share 2023-2028 (%)
Exhibits33: Data Table on Application - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Application
Exhibits35: Data Table on Comparison by Application
Exhibits36: Chart on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Diabetes - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Diabetes - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
Exhibits52: Market opportunity by Application ($ million)
Exhibits53: Data Table on Market opportunity by Application ($ million)
Exhibits54: Chart on End-user - Market share 2023-2028 (%)
Exhibits55: Data Table on End-user - Market share 2023-2028 (%)
Exhibits56: Chart on Comparison by End-user
Exhibits57: Data Table on Comparison by End-user
Exhibits58: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Self-administration - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Self-administration - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Self-administration - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Self-administration - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by End-user ($ million)
Exhibits67: Data Table on Market opportunity by End-user ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key news
Exhibits124: Amgen Inc. - Key offerings
Exhibits125: Bayer AG - Overview
Exhibits126: Bayer AG - Business segments
Exhibits127: Bayer AG - Key news
Exhibits128: Bayer AG - Key offerings
Exhibits129: Bayer AG - Segment focus
Exhibits130: Becton Dickinson and Co. - Overview
Exhibits131: Becton Dickinson and Co. - Business segments
Exhibits132: Becton Dickinson and Co. - Key news
Exhibits133: Becton Dickinson and Co. - Key offerings
Exhibits134: Becton Dickinson and Co. - Segment focus
Exhibits135: Eli Lilly and Co. - Overview
Exhibits136: Eli Lilly and Co. - Product / Service
Exhibits137: Eli Lilly and Co. - Key news
Exhibits138: Eli Lilly and Co. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Overview
Exhibits140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits141: F. Hoffmann La Roche Ltd. - Key news
Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits144: GlaxoSmithKline Plc - Overview
Exhibits145: GlaxoSmithKline Plc - Business segments
Exhibits146: GlaxoSmithKline Plc - Key news
Exhibits147: GlaxoSmithKline Plc - Key offerings
Exhibits148: GlaxoSmithKline Plc - Segment focus
Exhibits149: Halozyme Therapeutics Inc. - Overview
Exhibits150: Halozyme Therapeutics Inc. - Product / Service
Exhibits151: Halozyme Therapeutics Inc. - Key offerings
Exhibits152: Merck KGaA - Overview
Exhibits153: Merck KGaA - Business segments
Exhibits154: Merck KGaA - Key news
Exhibits155: Merck KGaA - Key offerings
Exhibits156: Merck KGaA - Segment focus
Exhibits157: Owen Mumford Ltd. - Overview
Exhibits158: Owen Mumford Ltd. - Product / Service
Exhibits159: Owen Mumford Ltd. - Key offerings
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Recipharm AB - Overview
Exhibits165: Recipharm AB - Business segments
Exhibits166: Recipharm AB - Key offerings
Exhibits167: Recipharm AB - Segment focus
Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits173: Viatris Inc. - Overview
Exhibits174: Viatris Inc. - Business segments
Exhibits175: Viatris Inc. - Key news
Exhibits176: Viatris Inc. - Key offerings
Exhibits177: Viatris Inc. - Segment focus
Exhibits178: Ypsomed Holding AG - Overview
Exhibits179: Ypsomed Holding AG - Business segments
Exhibits180: Ypsomed Holding AG - Key offerings
Exhibits181: Ypsomed Holding AG - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Information sources
Exhibits187: Data validation
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Data synthesis
Exhibits190: 360 degree market analysis
Exhibits191: List of abbreviations